These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22572726)

  • 1. Pigmented villonodular synovitis therapy with MSCF-1 inhibitors.
    Temple HT
    Curr Opin Oncol; 2012 Jul; 24(4):404-8. PubMed ID: 22572726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.
    Cassier PA; Gelderblom H; Stacchiotti S; Thomas D; Maki RG; Kroep JR; van der Graaf WT; Italiano A; Seddon B; Dômont J; Bompas E; Wagner AJ; Blay JY
    Cancer; 2012 Mar; 118(6):1649-55. PubMed ID: 21823110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis.
    Fiocco U; Sfriso P; Lunardi F; Pagnin E; Oliviero F; Scagliori E; Cozzi L; Vezzù M; Molena B; Scanu A; Panziera C; Nardacchione R; Rubaltelli L; Dayer JM; Calabrese F; Punzi L
    Autoimmun Rev; 2010 Sep; 9(11):780-4. PubMed ID: 20620241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis.
    Brahmi M; Vinceneux A; Cassier PA
    Curr Treat Options Oncol; 2016 Feb; 17(2):10. PubMed ID: 26820289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
    Cupp JS; Miller MA; Montgomery KD; Nielsen TO; O'Connell JX; Huntsman D; van de Rijn M; Gilks CB; West RB
    Am J Surg Pathol; 2007 Jun; 31(6):970-6. PubMed ID: 17527089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis.
    Ravi V; Wang WL; Lewis VO
    Curr Opin Oncol; 2011 Jul; 23(4):361-6. PubMed ID: 21577109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial.
    Gelderblom H; Cropet C; Chevreau C; Boyle R; Tattersall M; Stacchiotti S; Italiano A; Piperno-Neumann S; Le Cesne A; Ferraresi V; Penel N; Duffaud F; Cassier P; Toulmonde M; Casali P; Taieb S; Guillemaut S; Metzger S; Pérol D; Blay JY
    Lancet Oncol; 2018 May; 19(5):639-648. PubMed ID: 29571946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synovial colony-stimulating factor-1 mRNA expression in diffuse pigmented villonodular synovitis.
    Molena B; Sfriso P; Oliviero F; Pagnin E; Teramo A; Lunardi F; Stramare R; Scanu A; Nardacchione R; Rubaltelli L; Calabrese F; Punzi L; Fiocco U
    Clin Exp Rheumatol; 2011; 29(3):547-50. PubMed ID: 21640049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF-1R Inhibitor Development: Current Clinical Status.
    Peyraud F; Cousin S; Italiano A
    Curr Oncol Rep; 2017 Sep; 19(11):70. PubMed ID: 28875266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study.
    Cassier PA; Italiano A; Gomez-Roca CA; Le Tourneau C; Toulmonde M; Cannarile MA; Ries C; Brillouet A; Müller C; Jegg AM; Bröske AM; Dembowski M; Bray-French K; Freilinger C; Meneses-Lorente G; Baehner M; Harding R; Ratnayake J; Abiraj K; Gass N; Noh K; Christen RD; Ukarma L; Bompas E; Delord JP; Blay JY; Rüttinger D
    Lancet Oncol; 2015 Aug; 16(8):949-56. PubMed ID: 26179200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).
    Blay JY; El Sayadi H; Thiesse P; Garret J; Ray-Coquard I
    Ann Oncol; 2008 Apr; 19(4):821-2. PubMed ID: 18296418
    [No Abstract]   [Full Text] [Related]  

  • 12. Pigmented villonodular bursitis/diffuse giant cell tumor of the pes anserine bursa: a report of two cases and review of literature.
    Maheshwari AV; Muro-Cacho CA; Pitcher JD
    Knee; 2007 Oct; 14(5):402-7. PubMed ID: 17669658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of colony-stimulating factor 1 is associated with occurrence of osteochondral change in pigmented villonodular synovitis.
    Ota T; Urakawa H; Kozawa E; Ikuta K; Hamada S; Tsukushi S; Shimoyama Y; Ishiguro N; Nishida Y
    Tumour Biol; 2015 Jul; 36(7):5361-7. PubMed ID: 25854167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment updates on tenosynovial giant cell tumor.
    Palmerini E; Staals EL
    Curr Opin Oncol; 2022 Jul; 34(4):322-327. PubMed ID: 35837703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.
    West RB; Rubin BP; Miller MA; Subramanian S; Kaygusuz G; Montgomery K; Zhu S; Marinelli RJ; De Luca A; Downs-Kelly E; Goldblum JR; Corless CL; Brown PO; Gilks CB; Nielsen TO; Huntsman D; van de Rijn M
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):690-5. PubMed ID: 16407111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1/CSF1R signaling abnormalities in the cell line GDM1.
    Chase A; Schultheis B; Kreil S; Baxter J; Hidalgo-Curtis C; Jones A; Zhang L; Grand FH; Melo JV; Cross NC
    Leukemia; 2009 Feb; 23(2):358-64. PubMed ID: 18971950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor alpha blockade in treatment resistant pigmented villonodular synovitis.
    Kroot EJ; Kraan MC; Smeets TJ; Maas M; Tak PP; Wouters JM
    Ann Rheum Dis; 2005 Mar; 64(3):497-9. PubMed ID: 15297283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoclast formation and function in pigmented villonodular synovitis.
    Taylor R; Kashima TG; Knowles H; Gibbons CL; Whitwell D; Athanasou NA
    J Pathol; 2011 Sep; 225(1):151-6. PubMed ID: 21706481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The growing problem of benign connective tissue tumours.
    Thomas DM
    Lancet Oncol; 2015 Aug; 16(8):879-80. PubMed ID: 26179199
    [No Abstract]   [Full Text] [Related]  

  • 20. Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence.
    Martin RC; Osborne DL; Edwards MJ; Wrightson W; McMasters KM
    Oncol Rep; 2000; 7(2):413-9. PubMed ID: 10671695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.